KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Profit from core business operations before interest and taxes
Latest
$-203.03M
↓ 124% vs avg
Percentile
P0
Near historical low
Streak
8 yr
Consecutive declineContracting
Average
$-90.83M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-203.03M | -8.0% |
| 2025 | $-188.00M | -33.9% |
| 2024 | $-140.44M | -26.7% |
| 2023 | $-110.87M | -14.8% |
| 2022 | $-96.61M | -66.8% |
| 2021 | $-57.92M | -42.9% |
| 2020 | $-40.53M | -35.9% |
| 2019 | $-29.82M | -59.4% |
| 2018 | $-18.70M | +16.3% |
| 2017 | $-22.34M | - |